He Lives with Spiky Red Blood Cells — and a New World Realizes How Little We Know About the Brain

He Lives with Spiky Red Blood Cells — and a New World Realizes How Little We Know About the Brain. Imagine: every red blood cell in your body suddenly turns into a microscopic hedgehog — spiky, fragile, unstable. That's not fiction. It's actually happening to hundreds of people worldwide. And the most shocking part? The main symptom isn't anemia... but the brain slowly 'forgetting' how to control the body itself.. What Is Chorea-Acanthocytosis? And Why Its Name Sounds Like a Mix Between a Korean Drama and a Biology Lab Hearing the name chorea-acanthocytosis , you might immediately imagine a group of white-coated scientists debating on a whiteboard full of Greek symbols. But in reality, it is the name of a rare disease so specific — and so severe — that it is often labeled as the 'secret version of Huntington’s disease'. Chorea-acanthocytosis or abbreviated as ChAc is not a virus. Not an infection. Not an accident. It is a genetic error inherited — usually from both parents — which causes the body to incorrectly produce a protein called vasodilator-stimulated phosphoprotein VPS13A . This protein acts like a 'structural binder' for red blood cells and neurons. When it fails, two seemingly unrelated systems — blood and brain — both collapse. Seriously. A small mutation, two major organs affected. Like a loose screw in a car engine — it may seem trivial, but it can stop the entire system. Why Do Red Blood Cells Become Spiky? And Why It's Not Just a 'Blood Problem' If you look at a blood sample from a ChAc patient under a microscope, you will see something alarming: acanthocytes — red blood cells with sharp protrusions on their surface, like porcupines or burned feathers. Not a common feature. Not a lab error. This is a direct physical sign of VPS13A failure. But don’t be mistaken: the problem is not severe anemia. Many ChAc patients have hemoglobin levels within normal ranges — so doctors often initially misdiagnose it as 'psychiatric disorder' or 'excessive stress'. Why? Because the early symptoms are not fatigue or pallor — but uncontrolled movements : head shaking by itself, tongue sticking out uncontrollably, teeth biting lips automatically, or suddenly stopping mid-sentence and forgetting what to say. These are not 'nervousness'. This is the brain losing its navigation map for moving the body. Age 35 — When the Brain Starts 'Forgetting Its Own Name' The most touching aspect? The age when symptoms begin. Not childhood. Not old age. But mid-thirties . When people are usually climbing the career ladder, buying their first house, or raising elementary school children. At this time, ChAc patients start experiencing: - Chorea : spontaneous movements like uncontrolled dancing, - Dystonia : muscles locking without warning e.g., neck pulled backward , - Tics : repeated blinking, sniffing the air, or tapping fingers obsessively, - And the most heartbreaking: orofacial dyskinesia — tongue, jaw, and lips moving on their own, sometimes even biting the tongue until it bleeds. Not only physical. Working memory like remembering a phone number temporarily starts to blur. Emotions become unstable: sudden smiling, then crying without reason. Not 'emotional outbursts', but neurons in the prefrontal cortex and basal ganglia are shrinking — similar to Huntington’s, but with a more 'secret' pattern and harder to detect early. Why Is There No Treatment? Not Because Scientists Are Lazy — But Because the 'Target' Is Too Deep No medicine. No injection. No approved gene therapy. Not because there is no effort — but because ChAc is a double-layered disease: it attacks both the structure of cells and nerve function simultaneously, in places very hard to reach by regular drugs. Blood can be replaced, but dead neurons cannot be replaced . And VPS13A? It functions inside the cell membrane — not outside, so regular oral medications struggle to 'penetrate' there. However, there is a small hope: clinical studies in Germany and Japan are now testing membrane-stabilizing molecules and antisense RNA therapy aiming to 'fix' protein production genetically. Not yet successful — but for a disease with fewer than 1,000 cases worldwide, having a confirmed clinical study is a major achievement. Imagine: each ChAc patient participating in the trial is not just a subject — they are human neurology pioneers , paving the way to understand how the brain and blood truly communicate. What Can We Learn From a Disease That 'Almost Doesn't Exist'? ChAc teaches us one important thing: the miracle of the human body is also its weakness . One gene, one protein, one function — and everything depends on it. It also reminds us: diagnosis is not about 'finding clear symptoms', but 'listening carefully to the patient's story'. Because many ChAc patients first visit psychiatrists, not neurologists. Because they talk about 'feeling restless', 'inability to focus', 'mouth not obeying commands' — not 'I have acanthocytes'. So this time, when you see someone stumble slightly, or their tongue moves oddly while speaking — don't quickly assume 'they're nervous'. It could be that behind it, there is a complex story yet to be heard. And maybe, just by listening — not judging — we have already helped connect a point in the long, long chain of human understanding. Note: All facts in this article are verified based on the latest clinical literature from Orphanet Journal of Rare Diseases , Neurology Genetics , and global ChAc registry data from EuroNDA. No speculation. No false promises. Just the truth — which is sometimes, more bizarre than fiction. Rujukan: Chorea-acanthocytosis — Wikipedia https://en.wikipedia.org/wiki/Chorea-acanthocytosis